Literature DB >> 1281069

Mifepristone. Separating fact from fiction.

R C Henshaw1, A A Templeton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1281069     DOI： 10.2165/00003495-199244040-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  46 in total

1.  The use of mifepristone prior to prostaglandin-induced mid-trimester abortion.

Authors:  D R Urquhart; A A Templeton
Journal:  Hum Reprod       Date:  1990-10       Impact factor: 6.918

2.  Effects of the anti-progestin RU 38486 on rat embryos growing in culture.

Authors:  R P Hardy; D A New
Journal:  Food Chem Toxicol       Date:  1991-05       Impact factor: 6.023

3.  Antiprogestin drugs: medical and legal issues.

Authors:  R J Cook
Journal:  Fam Plann Perspect       Date:  1989 Nov-Dec

4.  The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial.

Authors: 
Journal:  Br J Obstet Gynaecol       Date:  1990-06

5.  Twenty one years of legal abortion.

Authors:  D Munday; C Francome; W Savage
Journal:  BMJ       Date:  1989-05-06

Review 6.  Pregnancy termination: techniques, risks, and complications and their management.

Authors:  R G Castadot
Journal:  Fertil Steril       Date:  1986-01       Impact factor: 7.329

7.  Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.

Authors:  M W Rodger; D T Baird
Journal:  Br J Obstet Gynaecol       Date:  1990-01

8.  Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.

Authors:  R Frydman; H Fernandez; J C Pons; A Ulmann
Journal:  Hum Reprod       Date:  1988-08       Impact factor: 6.918

9.  The efficacy of oral Mifepristone (RU 38,486) with a prostaglandin E1 analog vaginal pessary for the termination of early pregnancy: complications and patient acceptability.

Authors:  N C Hill; J Ferguson; I Z MacKenzie
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

10.  [Contraceptive activity of RU486 and oral active prostaglandin combination].

Authors:  E Aubeny; E E Baulieu
Journal:  C R Acad Sci III       Date:  1991
View more
  1 in total

Review 1.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.